| 摘要 |
The present invention relates to a composition for preventing, mitigating, or treating Th2-mediated immune diseases comprising one or more extracts selected from the group consisting of a Rhamnus davurica Pall. extract, a Chrysosplenium grayanum Maxim.extract, a Podocarpus macrophyllus extract, a Distylium racemosum Siebold & Zucc. extract, and a Rhododendron mucronulatum Turcz. extract. According to the present invention, the extracts controls IL-4 generation, controls penetration of an allergen into intestinal epithelial cells, and controls degranulation of mast cells, thereby preventing, mitigating, or treating Th2-mediated immune diseases. |
